home / openregs / dockets

dockets: FDA-2020-P-2322

Regulatory dockets from Regulations.gov — containers for related documents and comments in a rulemaking proceeding.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id title docket_type last_modified object_id rin dkabstract category subtype keywords program short_title effective_date organization attrs_raw attr_source
FDA-2020-P-2322 FDA Requests that the FDA withdraw the request for proposals regarding insulin reimportation programs issued on September 24, 2020. Nonrulemaking 2022-12-30T13:35:00Z 0b000064849bb906   CLOSED     ["Citizen Petition", "CDER", "Covington & Burling LLP", "Pharmaceutical Research and Manufacturers of", "America", "Withdraw the Request for Proposals", "Regarding Insulin Reimportation", "Programs", "issued on September 24, 2020", "Refrain from authorizing reimportation", "of insulin under section", "801(d)(2) unless", "insulin is in shortage as a result", "of a medical emergency", "Establish a process by which the drug", "manufacturer has notice and an", "opportunity to participate in the", "decision-making process with respect", "to an application for", "reimportation of its drug product", "under section 801(d)(2)", "Provide the public with notice", "whenever an application for drug", "reimportation", "under section 801(d)(2)", "has been approved"] CDER Requests that the FDA withdraw the request for proposals regarding insulin reimportation programs issued on September 24, 2020.     {"displayProperties": [{"name": "abstract", "label": "General Information", "tooltip": "Describes an agency's specific regulatory action; equivalents: Abstract, Description, Docket Subject, Related To, Summary."}, {"name": "generic", "label": "Docket Item Code", "tooltip": "An agency specific code that identifies the type of document that established the docket (regulatory action)."}, {"name": "program", "label": "Center", "tooltip": "The agency specific program associated with the docket (regulatory action); equivalents: Docket Item Code, Location."}, {"name": "field2", "label": "Docket Status", "tooltip": "Used to Identity that a Docket's Status is Open or Closed"}, {"name": "shortTitle", "label": "Short Title", "tooltip": "A combination of letters and or numbers assigned to an agency's regulatory action for purposes of brevity."}], "keywords": ["Citizen Petition", "CDER", "Covington & Burling LLP", "Pharmaceutical Research and Manufacturers of", "America", "Withdraw the Request for Proposals", "Regarding Insulin Reimportation", "Programs", "issued on September 24, 2020", "Refrain from authorizing reimportation", "of insulin under section", "801(d)(2) unless", "insulin is in shortage as a result", "of a medical emergency", "Establish a process by which the drug", "manufacturer has notice and an", "opportunity to participate in the", "decision-making process with respect", "to an application for", "reimportation of its drug product", "under section 801(d)(2)", "Provide the public with notice", "whenever an application for drug", "reimportation", "under section 801(d)(2)", "has been approved"], "modifyDate": "2022-12-30T13:35:00Z", "dkAbstract": "CLOSED", "agencyId": "FDA", "program": "CDER", "shortTitle": "Requests that the FDA withdraw the request for proposals regarding insulin reimportation programs issued on September 24, 2020.", "subType2": null, "title": "Requests that the FDA withdraw the request for proposals regarding insulin reimportation programs issued on September 24, 2020.", "generic": "P", "field1": null, "docketType": "Nonrulemaking", "petitionNbr": null, "rin": null, "organization": null, "legacyId": null, "subType": null, "category": null, "field2": "CLOSED", "effectiveDate": null, "objectId": "0b000064849bb906"} single_get

Links from other tables

  • 4 rows from docket_id in documents
Powered by Datasette · Queries took 0.548ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API · Privacy